Table of Contents

2019-2024 Global Asparaginase Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Asparaginase Consumption 2014-2024
  • 2.1.2 Asparaginase Consumption CAGR by Region
• 2.2 Asparaginase Segment by Type
  • 2.2.1 Escherichia Coli
  • 2.2.2 Erwinia Chrysanthemi
  • 2.2.3 Pegylated
• 2.3 Asparaginase Consumption by Type
  • 2.3.1 Global Asparaginase Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Asparaginase Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Asparaginase Sale Price by Type (2014-2019)
• 2.4 Asparaginase Segment by Application
  • 2.4.1 Acute Lymphoblastic Leukemia
  • 2.4.2 Acute Myeloid Leukemia
  • 2.4.3 Other
• 2.5 Asparaginase Consumption by Application
  • 2.5.1 Global Asparaginase Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Asparaginase Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Asparaginase Sale Price by Application (2014-2019)

3 Global Asparaginase by Players

• 3.1 Global Asparaginase Sales Market Share by Players
  • 3.1.1 Global Asparaginase Sales by Players (2017-2019)
  • 3.1.2 Global Asparaginase Sales Market Share by Players (2017-2019)
• 3.2 Global Asparaginase Revenue Market Share by Players
  • 3.2.1 Global Asparaginase Revenue by Players (2017-2019)
  • 3.2.2 Global Asparaginase Revenue Market Share by Players (2017-2019)
• 3.3 Global Asparaginase Sale Price by Players
• 3.4 Global Asparaginase Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Asparaginase Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Asparaginase Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Asparaginase by Regions

• 4.1 Asparaginase by Regions
  • 4.1.1 Global Asparaginase Consumption by Regions
  • 4.1.2 Global Asparaginase Value by Regions
• 4.2 Americas Asparaginase Consumption Growth
• 4.3 APAC Asparaginase Consumption Growth
• 4.4 Europe Asparaginase Consumption Growth
• 4.5 Middle East & Africa Asparaginase Consumption Growth

5 Americas

• 5.1 Americas Asparaginase Consumption by Countries
  • 5.1.1 Americas Asparaginase Consumption by Countries (2014-2019)
  • 5.1.2 Americas Asparaginase Value by Countries (2014-2019)
• 5.2 Americas Asparaginase Consumption by Type
• 5.3 Americas Asparaginase Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Asparaginase Consumption by Countries
  • 6.1.1 APAC Asparaginase Consumption by Countries (2014-2019)
  • 6.1.2 APAC Asparaginase Value by Countries (2014-2019)
• 6.2 APAC Asparaginase Consumption by Type
• 6.3 APAC Asparaginase Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Asparaginase by Countries
  • 7.1.1 Europe Asparaginase Consumption by Countries (2014-2019)
  • 7.1.2 Europe Asparaginase Value by Countries (2014-2019)
• 7.2 Europe Asparaginase Consumption by Type
• 7.3 Europe Asparaginase Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Asparaginase by Countries
  • 8.1.1 Middle East & Africa Asparaginase Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Asparaginase Value by Countries (2014-2019)
• 8.2 Middle East & Africa Asparaginase Consumption by Type
• 8.3 Middle East & Africa Asparaginase Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Asparaginase Distributors
• 10.3 Asparaginase Customer

11 Global Asparaginase Market Forecast

• 11.1 Global Asparaginase Consumption Forecast (2019-2024)
• 11.2 Global Asparaginase Forecast by Regions
  • 11.2.1 Global Asparaginase Forecast by Regions (2019-2024)
  • 11.2.2 Global Asparaginase Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Asparaginase Forecast by Type
• 11.8 Global Asparaginase Forecast by Application

12 Key Players Analysis

• 12.1 Jazz Pharmaceuticals
  • 12.1.1 Company Details
  • 12.1.2 Asparaginase Product Offered
  • 12.1.3 Jazz Pharmaceuticals Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Jazz Pharmaceuticals News
• 12.2 Shire
  • 12.2.1 Company Details
  • 12.2.2 Asparaginase Product Offered
  • 12.2.3 Shire Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Shire News
• 12.3 Medac GmbH
  • 12.3.1 Company Details
  • 12.3.2 Asparaginase Product Offered
  • 12.3.3 Medac GmbH Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Medac GmbH News
• 12.4 Kyowa Hakko Kirin
  • 12.4.1 Company Details
  • 12.4.2 Asparaginase Product Offered
  • 12.4.3 Kyowa Hakko Kirin Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Kyowa Hakko Kirin News
• 12.5 Qianhong Bio-pharma
  • 12.5.1 Company Details
  • 12.5.2 Asparaginase Product Offered
  • 12.5.3 Qianhong Bio-pharma Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Qianhong Bio-pharma News
• 12.6 Taj Pharmaceuticals
  • 12.6.1 Company Details
  • 12.6.2 Asparaginase Product Offered
  • 12.6.3 Taj Pharmaceuticals Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Taj Pharmaceuticals News
• 12.7 Mingxing Pharma
  • 12.7.1 Company Details
  • 12.7.2 Asparaginase Product Offered
  • 12.7.3 Mingxing Pharma Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Mingxing Pharma News
• 12.8 SL Pharma
  • 12.8.1 Company Details
  • 12.8.2 Asparaginase Product Offered
  • 12.8.3 SL Pharma Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.8.4 Main Business Overview
  • 12.8.5 SL Pharma News
• 12.9 United Biotech
  • 12.9.1 Company Details
  • 12.9.2 Asparaginase Product Offered
  • 12.9.3 United Biotech Asparaginase Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.9.4 Main Business Overview
  • 12.9.5 United Biotech News

13 Research Findings and Conclusion

Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.

Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available.
Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
In the last several years, global market of Asparaginase developed stably, with an average growth rate of 1.4%. In 2017, global revenue of Asparaginase is nearly 390 M USD; the actual production is about 590 K Units.

According to this study, over the next five years the Asparaginase market will register a 1.3% CAGR in terms of revenue, the global market size will reach US$ 410 million by 2024, from US$ 380 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Asparaginase business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Asparaginase market by product type, application, key manufacturers and key regions and countries.

This study considers the Asparaginase value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Escherichia Coli
Erwinia Chrysanthemi
Pegylated
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Jazz Pharmaceuticals
Shire
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Asparaginase consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Asparaginase market by identifying its various subsegments.
Focuses on the key global Asparaginase manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Asparaginase with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Asparaginase submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.